Histotripsy treatment of benign prostatic enlargement using the Vortx Rx system: Initial human safety and efficacy outcomes
Urology Jan 14, 2018
Schuster TG, et al. - This trial was formulated in order to investigate the clinical safety (primary) and efficacy (secondary) of histotripsy for the treatment of symptomatic benign prostatic enlargement (BPE). Researchers drew the conclusion that prostate histotripsy was a safe and well-tolerated technique, leading to an improvement in the lower urinary tract symptoms (LUTS).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries